Kidney Disease

Affymax shares plunge on drug safety concerns

NYC hospital wins kidney transplant-cancer lawsuit

Amgen shares dip on anemia drug concerns

Keryx agrees with FDA on kidney drug trial design

NEW YORK - Shares of Affymax Inc.

NEW YORK - A prominent organ-transplant hospital wasn't to blame for the death of a man who became riddled with cancer after getting a kidney from a donor who unknowingly had uterine cancer, jurors found Friday.

MORE..

NEW YORK - Shares of Amgen Inc.

MORE..

Older News

NEW YORK - Keryx Biopharmaceuticals Inc.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy